Blog

Bristol-Myers to invest in Dutch gene therapy company uniQure

(Reuters) – Bristol-Myers Squibb Co said it would invest in Dutch biotech uniQure NV, joining other big drugmakers who have moved to gain a foothold in the promising gene therapy market. UniQure’s shares jumped more than 55 percent on Monday after Bristol-Myers said it would pick up a 4.9 percent stake in the company. UniQure’s gene therapy drug, Glyberan, went on sale last year priced at 1.1 million euros. Investor

Less than recommended physical activity may still lengthen life

During many years of follow-up, people who did less than the minimum recommended amount of physical activity still had a considerable decrease in risk of death compared to people who did no activity at all, in a new analysis of six studies. “Our findings support the 2008 Physical Activity Guidelines for Americans, which recommend a minimum of 150 minutes of moderate-intensity or 75 minutes of vigorous-intensity activity per week for